Home Cart Sign in  
Chemical Structure| 211555-04-3 Chemical Structure| 211555-04-3

Structure of WHI-P154
CAS No.: 211555-04-3

Chemical Structure| 211555-04-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

WHI-P154 is a specific inhibitor of JAK3 with IC50 value of 1.8 μM, almost shows no activity against JAK1 or JAK2.

Synonyms: JAK3 Inhibitor II; Janus-Associated Kinase 3 Inhibitor II; Janex1.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of WHI-P154

CAS No. :211555-04-3
Formula : C16H14BrN3O3
M.W : 376.20
SMILES Code : OC1=CC=C(NC2=C3C=C(OC)C(OC)=CC3=NC=N2)C=C1Br
Synonyms :
JAK3 Inhibitor II; Janus-Associated Kinase 3 Inhibitor II; Janex1.
MDL No. :MFCD02179366
InChI Key :CBIAKDAYHRWZCU-UHFFFAOYSA-N
Pubchem ID :3795

Safety of WHI-P154

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of WHI-P154

epigenetics
RTK
JAK-STAT

Isoform Comparison

Biological Activity

Target
  • JAK3

    JAK3, IC50:1.8 μM

  • EGFR/ErbB1

    EGFR, IC50:4 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
BMMCs 3, 10, 30 µM 20 min Inhibited the antigen-induced degranulation and activation of MAPKs PMC1576194
HEK293/pcDNA3.1 cells 4 µM 72 h WHI-P154 did not significantly affect HEK293/pcDNA3.1 cells. PMC4317847
H460/MX20 cells 4 µM 72 h WHI-P154 significantly enhanced the sensitivity of H460/MX20 cells to ABCG2 substrates and moderately increased the sensitivity of H460 cells. PMC4317847
RBL-2H3 cells 3, 10, 30 µM 20 min Inhibited the antigen-induced degranulation and phosphorylation of p44/42 MAPK, p38 MAPK, and JNK PMC1576194

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Xenograft model Intravenous injection 1 mg/kg Daily, continuous treatment WHI-P154 treatment significantly inhibited tumor growth and lung metastasis induced by H694R and E1384K mutant ALKs, and prolonged the survival of nude mice. PMC3156661

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.66mL

0.53mL

0.27mL

13.29mL

2.66mL

1.33mL

26.58mL

5.32mL

2.66mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories